Skip to content

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Anti-Stress Efficacy of Complementary-Alternative Medicine in Healthy subjects

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Anti-Stress Efficacy of Complementary-Alternative Medicine in Healthy subjects - A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Anti-Stress Efficacy of Complementary-Alternative Medicine in Healthy subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042849
Enrollment
40
Registered
2021-01-01
Start date
2021-01-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Interventions

Oral ingestion of the test product NBC_H1 (4 pills/day
2 weeks). Oral ingestion of the placebo products NBC_H1P (4 pills/day

Sponsors

Hyogo University of Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Subject agreeing to participate in the study with signing a written informed consent 2) Males and females whose age of 20-65 years at signing informed consent. 3)Subjects who are healthy and are not have chronic diseases

Exclusion criteria

Exclusion criteria: 1)Subjects who have a history of cardiac diseases like arrhythmia. 2)Subjects who have a history of allergic symptoms by the ginseng. 3)Subjects who have a history of allergic symptoms by food. 4)Subjects who have a history of mental disease. 5)Subjects who have a history of using antipsychotic drug. 6)Subjects who use a drug to treat a disease. 7)Subjects who ingest supplements or energy drinks include ginseng. 8)Subjects who can't stop use of health food such as supplements, energy drinks. 9)Subjects who are a color-blind person. 10)Subjects who are a smoker. 11)Subjects who have abnormal score of amylase and cortisol in saliva, blood pressure and heart rate. 12)Subjects who suffered pain usually. 13)Subjects who participated in other clinical studies. 14)Subjects who take foods or dinks which are not provided from noon to fifteen on the day of study.

Design outcomes

Primary

MeasureTime frame
Effect of oral administration (single administration or 2 weeks continuous administration) of food material NBC_H1 on the following index: Blood pressure, Heart rate, Score of amylase in saliva, Score of cortisol in saliva, Score of D2-concentration Test(speed of task, rate of error, omission error, commission error)

Countries

Japan

Contacts

Public ContactYOKO KOGURE

Hyogo University of Health Scineces School of Pharmacy

stress-relief@ml.huhs.ac.jp078-304-3166

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026